{"id":"cardioplegia-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Myocardial edema"},{"rate":null,"effect":"Reperfusion injury"},{"rate":null,"effect":"Arrhythmias post-operatively"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The solution works by creating a controlled, reversible cessation of cardiac contractions through potassium-induced depolarization, reducing myocardial oxygen demand during the ischemic period of surgery. It simultaneously provides essential substrates (glucose, amino acids) and buffering agents to preserve cellular function and prevent ischemic injury, allowing the surgeon to operate on a still, bloodless field while maintaining myocardial viability for post-operative recovery.","oneSentence":"Cardioplegia solution induces rapid cardiac arrest and provides myocardial protection during cardiac surgery by delivering a balanced electrolyte and metabolic substrate solution to the heart.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:17:20.637Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial protection during cardiac surgery requiring cardiopulmonary bypass"}]},"trialDetails":[{"nctId":"NCT06287372","phase":"","title":"Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia","status":"COMPLETED","sponsor":"Damascus University","startDate":"2022-07-04","conditions":"Myocardial Injury, Cardiac Surgery, Myocardial Protection","enrollment":20},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT07426237","phase":"PHASE4","title":"Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2026-03-30","conditions":"Myocardial Protection","enrollment":60},{"nctId":"NCT07386990","phase":"PHASE4","title":"Cardioplegic Protection of the Heart","status":"COMPLETED","sponsor":"Region Skane","startDate":"2021-06-15","conditions":"Coronary Artery Bypass Graft (CABG), Cardioplegia, Cardiopulmonary Bypass","enrollment":40},{"nctId":"NCT07381530","phase":"PHASE2","title":"Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children","status":"SUSPENDED","sponsor":"Dr. F. Köhler Chemie GmbH","startDate":"2024-12-05","conditions":"Congenital Heart Malformations","enrollment":100},{"nctId":"NCT07358221","phase":"NA","title":"Impact of Different Cardioplegia Solutions on Indicators of Myocardial Injury During Coronary Surgery","status":"NOT_YET_RECRUITING","sponsor":"Damascus University","startDate":"2026-02","conditions":"Coronary Artery Bypass Grafting (CABG) Surgery, Myocardial Protection","enrollment":30},{"nctId":"NCT06793670","phase":"PHASE4","title":"Landiolol in Mitral Valve Surgery","status":"RECRUITING","sponsor":"Università Vita-Salute San Raffaele","startDate":"2025-01-28","conditions":"Cardiac Failure, Low Cardiac Output Syndrome","enrollment":1500},{"nctId":"NCT06414330","phase":"PHASE3","title":"Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-06-01","conditions":"Cardiac Ischemia","enrollment":124},{"nctId":"NCT07205757","phase":"PHASE4","title":"Adding Lidocaine to Custodiol Mixture","status":"RECRUITING","sponsor":"Fayoum University Hospital","startDate":"2025-10-03","conditions":"CAD, Arrhythmia Ventricular","enrollment":70},{"nctId":"NCT03627013","phase":"PHASE3","title":"Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)","status":"RECRUITING","sponsor":"Dr. F. Köhler Chemie GmbH","startDate":"2019-05-23","conditions":"Kidney Failure, Liver Failure, Chronic, Kidney-Pancreas Failure","enrollment":362},{"nctId":"NCT04094168","phase":"PHASE4","title":"Clinical Impact of Del Nido Cardioplegia in Adult Cardiac Surgery","status":"COMPLETED","sponsor":"JESSICA GARCIA SUAREZ","startDate":"2018-06-15","conditions":"Heart; Surgery, Heart, Functional Disturbance as Result","enrollment":474},{"nctId":"NCT04259515","phase":"PHASE4","title":"Buckberg vs Del Nido in Isolated Aortic Valve Replacement","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2019-07-16","conditions":"Cardiac Surgical Procedures","enrollment":286},{"nctId":"NCT04066127","phase":"NA","title":"Non-ischaemic Heart Preservation Versus Standard Cold Storage in Human Heart Transplantation","status":"ENROLLING_BY_INVITATION","sponsor":"Region Skane","startDate":"2020-07-01","conditions":"Transplant; Failure, Heart","enrollment":66},{"nctId":"NCT06530641","phase":"PHASE4","title":"Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery.","status":"RECRUITING","sponsor":"Lourdes Montero Cruces","startDate":"2024-12-01","conditions":"Cardiac Surgery, Cardioplegia, Heart Arrest","enrollment":600},{"nctId":"NCT05627479","phase":"PHASE2","title":"MAGIK for Femoral/Tibial Shaft Fractures","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-12-01","conditions":"Femoral Shaft Fracture, Tibial Shaft Fracture","enrollment":""},{"nctId":"NCT05927090","phase":"","title":"Outcomes of Aortic Dissection Repair","status":"ENROLLING_BY_INVITATION","sponsor":"Centre Cardiologique du Nord","startDate":"2005-01-01","conditions":"Type A Aortic Dissection, Ascending Aortic Dissection, Aortic Diseases","enrollment":1200},{"nctId":"NCT05912634","phase":"","title":"Repair Versus Non-repair of the Aortic Arch in Type A Aortic Dissection","status":"ENROLLING_BY_INVITATION","sponsor":"Centre Cardiologique du Nord","startDate":"2014-01-01","conditions":"Aortic Dissection, Aortic Arch, Aortic Dissection Rupture","enrollment":900},{"nctId":"NCT05912608","phase":"NA","title":"Optimal Strategy for Repair of Type A Acute Aortic Dissection","status":"ENROLLING_BY_INVITATION","sponsor":"Centre Cardiologique du Nord","startDate":"2024-01-01","conditions":"Aortic Dissection","enrollment":900},{"nctId":"NCT06744088","phase":"","title":"Clinical Outcomes Of Modified Del Nido Cardioplegia In Adult And Pediatric Cardiac Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2024-02-28","conditions":"Cardiac Events","enrollment":200},{"nctId":"NCT05076604","phase":"PHASE4","title":"Effects of Microplegia on Transfusion Rates After Cardiac Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-03-25","conditions":"Aortic Valve Disease, Mitral Valve Disease","enrollment":314},{"nctId":"NCT06373549","phase":"","title":"Investigation of Myocardial Protection Efficacy of Cardioplegia Solutions Used in Open Heart Surgery","status":"COMPLETED","sponsor":"Tamer cebe","startDate":"2022-12-08","conditions":"Cardiovascular Diseases, Myocardial Reperfusion Injury","enrollment":2},{"nctId":"NCT04051580","phase":"NA","title":"Comparison of Lactated Ringer's Solution and PlasmaLyte-A as a Base Solution for Del Nido Cardioplegia","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2019-08-05","conditions":"Myocardial Injury","enrollment":200},{"nctId":"NCT06235424","phase":"PHASE4","title":"Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2018-10-01","conditions":"Aortic Valve Disease, Valve Disease, Heart, Cardiac Ischemia","enrollment":100},{"nctId":"NCT05464966","phase":"NA","title":"The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2022-06-01","conditions":"Insulin","enrollment":74},{"nctId":"NCT05221294","phase":"NA","title":"Modified Del Nido Versus Custodiol Cardioplegia For Myocardial Protection In Cardiac Surgery.","status":"COMPLETED","sponsor":"Fayoum University Hospital","startDate":"2022-02-01","conditions":"Cardioplegia Solution Adverse Reaction","enrollment":58},{"nctId":"NCT05603429","phase":"","title":"Investigation of Myocardial Protection Level With Specific Cardioplegia Methods in Cardiac Surgery","status":"COMPLETED","sponsor":"Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital","startDate":"2022-10-13","conditions":"Bypass Complication, Cardioplegia Solution Adverse Reaction, Endothelial Degeneration","enrollment":74},{"nctId":"NCT03216720","phase":"NA","title":"Miniaturized Extracorporeal Circulation Study","status":"COMPLETED","sponsor":"Aarhus University Hospital Skejby","startDate":"2017-09-28","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT05797090","phase":"NA","title":"Comparative Study Between Conventional Crystalloid Cardioplegic Solution With Modified Del Nido Cardioplegia","status":"COMPLETED","sponsor":"mohamed","startDate":"2022-07-01","conditions":"Mitral Valve Surgery","enrollment":80},{"nctId":"NCT05647200","phase":"NA","title":"Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II","status":"UNKNOWN","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-10-15","conditions":"Endothelial Dysfunction, Hemolysis, Fluid Overload","enrollment":64},{"nctId":"NCT03082716","phase":"PHASE2","title":"Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery","status":"COMPLETED","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2016-03-16","conditions":"Congenital Heart Disease","enrollment":49},{"nctId":"NCT04870073","phase":"PHASE3","title":"Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery","status":"WITHDRAWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2022-09-21","conditions":"Hemodilution, Coronary Artery Disease, Fluid Overload","enrollment":""},{"nctId":"NCT02442050","phase":"NA","title":"Del Nido Cardioplegia Randomized Trial","status":"TERMINATED","sponsor":"Inova Health Care Services","startDate":"2015-01","conditions":"Cardiac Perfusion","enrollment":99},{"nctId":"NCT03823521","phase":"PHASE3","title":"Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™","status":"COMPLETED","sponsor":"Swiss Cardio Technologies AG","startDate":"2018-11-20","conditions":"Coronary Artery Bypass Surgery, Valve Surgery","enrollment":171},{"nctId":"NCT05073094","phase":"PHASE4","title":"Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2021-10-06","conditions":"Hypertrophic Obstructive Cardiomyopathy","enrollment":80},{"nctId":"NCT02757443","phase":"PHASE3","title":"Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2016-06","conditions":"Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation","enrollment":120},{"nctId":"NCT03150147","phase":"NA","title":"A Randomized Controlled Trial Comparing Non-ischemic to Ischemic Preservation in Adult Cardiac Transplantation","status":"COMPLETED","sponsor":"Region Skane","startDate":"2017-03-01","conditions":"Transplant; Failure, Heart","enrollment":47},{"nctId":"NCT04476342","phase":"NA","title":"Integration of Minimal Invasive Cardiopulmonary Bypass System and the Research of Its Blood Compatibility","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-06-01","conditions":"Cardiopulmonary Bypass, Cardiac Surgery","enrollment":80},{"nctId":"NCT00855712","phase":"NA","title":"Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation","status":"COMPLETED","sponsor":"TransMedics","startDate":"2009-03","conditions":"Heart Failure","enrollment":128},{"nctId":"NCT04203680","phase":"EARLY_PHASE1","title":"Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-12-25","conditions":"Cardioplegia Solution Adverse Reaction","enrollment":320},{"nctId":"NCT04309994","phase":"","title":"Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2010-02-01","conditions":"Heart Attack, Cardioplegia Solution Adverse Reaction, Coronary Artery Bypass Grafting (CABG)","enrollment":307},{"nctId":"NCT04306913","phase":"NA","title":"Outcome of Esmolol Potassium Cardioplegia Compared to Potassium Cardioplegia in Patients With Solitary Valvular Disease; Randomized Controlled Study","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2020-04","conditions":"Cardioplegia Solution Adverse Reaction","enrollment":80},{"nctId":"NCT02098772","phase":"PHASE3","title":"Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol","status":"COMPLETED","sponsor":"Dr. F. Köhler Chemie GmbH","startDate":"2014-05","conditions":"Aortic Valve Disease, Coronary Artery Disease (CAD)","enrollment":530},{"nctId":"NCT03818113","phase":"","title":"Clinical Comparative Analysis of Bretschneider and St. Thomas Cardioplegia Solution in Case of Mitral Valve Repair Via Anterolateral Right Thoracotomy","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-04-01","conditions":"Mitral Valve Reconstruction","enrollment":200},{"nctId":"NCT01500785","phase":"PHASE4","title":"Intracoronary Administration of Levosimendan in Cardiac Surgery Patients","status":"TERMINATED","sponsor":"Tampere University Hospital","startDate":"2018-06-15","conditions":"Myocardial Stunning","enrollment":50},{"nctId":"NCT01681095","phase":"PHASE2","title":"Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent","status":"COMPLETED","sponsor":"Marc Sakwa, MD","startDate":"2012-08","conditions":"Coronary Artery Disease, Myocardial Ischemia, Coronary Disease","enrollment":110},{"nctId":"NCT03612388","phase":"","title":"Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2010-02-28","conditions":"Complication of Extracorporeal Circulation, Complication of Coronary Artery Bypass Graft","enrollment":211},{"nctId":"NCT03876067","phase":"PHASE2, PHASE3","title":"The Cardioprotective Effects of Adding Ozone To Cardioplegic Solution in Adult Cardiac Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-04-01","conditions":"Ischemic Heart Disease","enrollment":40},{"nctId":"NCT03818126","phase":"NA","title":"The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement","status":"COMPLETED","sponsor":"Pawel Buszman","startDate":"2016-07-01","conditions":"Aortic Valve Disease, Ischemia-reperfusion Injury","enrollment":150},{"nctId":"NCT03229980","phase":"PHASE2","title":"Pediatric Myocardial Protection With Potassium Cardioplegia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-08-10","conditions":"Cardioplegia","enrollment":87},{"nctId":"NCT03258333","phase":"","title":"Small Aortic Annulus - a New Solution to the Old Problem","status":"UNKNOWN","sponsor":"The Federal Centre of Cardiovascular Surgery, Russia","startDate":"2017-02-18","conditions":"Aortic Valve Replacement","enrollment":60},{"nctId":"NCT02681913","phase":"PHASE2","title":"Adenosine as an Adjunct to Blood Cardioplegia","status":"UNKNOWN","sponsor":"Amphia Hospital","startDate":"2016-02","conditions":"Pathological Processes, Cardiomyopathies","enrollment":100},{"nctId":"NCT03038204","phase":"","title":"The Papillary Muscle Approximation Provide Stability of Mitral Valve Repair for Ischemic Mitral Regurgitation","status":"UNKNOWN","sponsor":"The Federal Centre of Cardiovascular Surgery, Russia","startDate":"2016-02","conditions":"Mitral Regurgitation","enrollment":100},{"nctId":"NCT00788242","phase":"NA","title":"The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Christoph Ellenberger","startDate":"2009-01","conditions":"Aortic Stenosis, Coronary Heart Disease, Heart Failure","enrollment":200},{"nctId":"NCT00091507","phase":"PHASE3","title":"IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2006-11","conditions":"Angina, Unstable, Cardiovascular Diseases, Heart Diseases","enrollment":911},{"nctId":"NCT02618824","phase":"PHASE2","title":"Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery","status":"UNKNOWN","sponsor":"National Cardiovascular Center Harapan Kita Hospital Indonesia","startDate":"2015-12","conditions":"Congenital Heart Disease","enrollment":110},{"nctId":"NCT02646254","phase":"PHASE4","title":"Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique","status":"COMPLETED","sponsor":"SUNDER LAL NEGI","startDate":"2014-06","conditions":"Myocardial Protection in TOF Repair","enrollment":56},{"nctId":"NCT02591927","phase":"PHASE3","title":"Reappraisal of GIK in Acute STEMI by Pre-hospital Administration","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2016-02","conditions":"Myocardial Infarction","enrollment":334},{"nctId":"NCT00872001","phase":"PHASE3","title":"The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-04","conditions":"Coronary Artery Bypass, Myocardial Infarction, Ventricular Dysfunction, Left","enrollment":3080},{"nctId":"NCT01516138","phase":"PHASE2","title":"Benefits of GIK in Cardiac Surgery Patients","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2012-02","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":930},{"nctId":"NCT02248415","phase":"NA","title":"Administration of Warm Blood Cardioplegia With or Without Roller Pump","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2012-09","conditions":"Coronary Disease","enrollment":68},{"nctId":"NCT01614951","phase":"PHASE4","title":"The Pulmonary Protection Trial","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2012-07","conditions":"Chronic Obstructive Lung Disease","enrollment":90},{"nctId":"NCT01444235","phase":"PHASE2","title":"Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Dr. F. Köhler Chemie GmbH","startDate":"2011-03","conditions":"Coronary Artery Disease (CAD)","enrollment":102},{"nctId":"NCT01384656","phase":"PHASE4","title":"Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2011-02","conditions":"Acute Coronary Syndrome","enrollment":66},{"nctId":"NCT01401140","phase":"PHASE3","title":"Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2010-06","conditions":"Coronary Artery Stenosis","enrollment":29},{"nctId":"NCT01548872","phase":"PHASE4","title":"Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery","status":"UNKNOWN","sponsor":"Baskent University","startDate":"2011-12","conditions":"Myocardial Injury","enrollment":60},{"nctId":"NCT01123525","phase":"PHASE1, PHASE2","title":"Adenosine Cardioplegia; Improved Cardioprotection?","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2010-04","conditions":"Angina Pectoris","enrollment":60},{"nctId":"NCT00990795","phase":"PHASE1","title":"Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-04","conditions":"Cardiac Surgical Procedures","enrollment":72},{"nctId":"NCT00921596","phase":"PHASE1, PHASE2","title":"Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass (CPB)","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2000-01","conditions":"Congenital Heart Defects, Heart Valve Diseases","enrollment":800},{"nctId":"NCT00899483","phase":"NA","title":"Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?","status":"UNKNOWN","sponsor":"University Hospital Birmingham","startDate":"2009-07","conditions":"Type 2 Diabetes","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":283,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cardioplexol™"],"phase":"marketed","status":"active","brandName":"Cardioplegia Solution","genericName":"Cardioplegia Solution","companyName":"Washington University School of Medicine","companyId":"washington-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cardioplegia solution induces rapid cardiac arrest and provides myocardial protection during cardiac surgery by delivering a balanced electrolyte and metabolic substrate solution to the heart. Used for Myocardial protection during cardiac surgery requiring cardiopulmonary bypass.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}